SMTL ID : 4i4g.2 (1 other biounit)

Crystal structure of CYP3A4 ligated to oxazole-substituted desoxyritonavir

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.72 Å

Oligo State

homo-tetramer

Ligands

4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.1: 27 residues within 4Å: Chain A: R.85, I.98, S.99, W.106, R.110, I.281, F.282, A.285, T.289, V.293, I.349, A.350, L.353, R.355, P.414, F.415, G.416, S.417, R.420, N.421, C.422, I.423, G.424, F.427, A.428, M.432 Ligands: Z8Z.2 21 PLIP interactions: 21 interactions with chain A, Hydrophobic interactions: A:I.98, A:I.281, A:F.282, A:A.285, A:T.289, A:V.293, A:I.349, A:A.350, A:L.353, A:F.415, A:F.415, A:I.423, A:F.427 Hydrogen bonds: A:S.417, A:S.417 Salt bridges: A:R.85, A:R.85, A:R.110, A:R.355, A:R.420 Metal complexes: A:C.422 HEM.3: 27 residues within 4Å: Chain B: R.85, I.98, S.99, W.106, R.110, I.281, F.282, A.285, T.289, V.293, I.349, A.350, L.353, R.355, P.414, F.415, G.416, S.417, R.420, N.421, C.422, I.423, G.424, F.427, A.428, M.432 Ligands: Z8Z.4 21 PLIP interactions: 21 interactions with chain B, Hydrophobic interactions: B:I.98, B:I.281, B:F.282, B:A.285, B:T.289, B:V.293, B:I.349, B:A.350, B:L.353, B:F.415, B:F.415, B:I.423, B:F.427 Hydrogen bonds: B:S.417, B:S.417 Salt bridges: B:R.85, B:R.85, B:R.110, B:R.355, B:R.420 Metal complexes: B:C.422 HEM.5: 27 residues within 4Å: Chain C: R.85, I.98, S.99, W.106, R.110, I.281, F.282, A.285, T.289, V.293, I.349, A.350, L.353, R.355, P.414, F.415, G.416, S.417, R.420, N.421, C.422, I.423, G.424, F.427, A.428, M.432 Ligands: Z8Z.6 21 PLIP interactions: 21 interactions with chain C, Hydrophobic interactions: C:I.98, C:I.281, C:F.282, C:A.285, C:T.289, C:V.293, C:I.349, C:A.350, C:L.353, C:F.415, C:F.415, C:I.423, C:F.427 Hydrogen bonds: C:S.417, C:S.417 Salt bridges: C:R.85, C:R.85, C:R.110, C:R.355, C:R.420 Metal complexes: C:C.422 HEM.7: 27 residues within 4Å: Chain D: R.85, I.98, S.99, W.106, R.110, I.281, F.282, A.285, T.289, V.293, I.349, A.350, L.353, R.355, P.414, F.415, G.416, S.417, R.420, N.421, C.422, I.423, G.424, F.427, A.428, M.432 Ligands: Z8Z.8 21 PLIP interactions: 21 interactions with chain D, Hydrophobic interactions: D:I.98, D:I.281, D:F.282, D:A.285, D:T.289, D:V.293, D:I.349, D:A.350, D:L.353, D:F.415, D:F.415, D:I.423, D:F.427 Hydrogen bonds: D:S.417, D:S.417 Salt bridges: D:R.85, D:R.85, D:R.110, D:R.355, D:R.420 Metal complexes: D:C.422

4 x Z8Z: N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-N-[(2R,5R)-5-{[(1,3-oxazol-5-ylmethoxy)carbonyl]amino}-1,6-diphenylhexan-2-yl]-L-valinamide(Non-covalent)

Z8Z.2: 19 residues within 4Å: Chain A: D.56, R.85, R.86, F.88, S.99, I.100, L.190, L.191, F.193, T.204, F.221, I.281, F.284, A.285, T.289, A.350, R.352, E.354 Ligands: HEM.1 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:F.88, A:F.88, A:I.100, A:I.100, A:L.190, A:L.191, A:F.193, A:F.221, A:I.281, A:F.284, A:F.284, A:A.350 Hydrogen bonds: A:S.99 Z8Z.4: 19 residues within 4Å: Chain B: D.56, R.85, R.86, F.88, S.99, I.100, L.190, L.191, F.193, T.204, F.221, I.281, F.284, A.285, T.289, A.350, R.352, E.354 Ligands: HEM.3 13 PLIP interactions: 13 interactions with chain B Hydrophobic interactions: B:F.88, B:F.88, B:I.100, B:I.100, B:L.190, B:L.191, B:F.193, B:F.221, B:I.281, B:F.284, B:F.284, B:A.350 Hydrogen bonds: B:S.99 Z8Z.6: 19 residues within 4Å: Chain C: D.56, R.85, R.86, F.88, S.99, I.100, L.190, L.191, F.193, T.204, F.221, I.281, F.284, A.285, T.289, A.350, R.352, E.354 Ligands: HEM.5 13 PLIP interactions: 13 interactions with chain C Hydrophobic interactions: C:F.88, C:F.88, C:I.100, C:I.100, C:L.190, C:L.191, C:F.193, C:F.221, C:I.281, C:F.284, C:F.284, C:A.350 Hydrogen bonds: C:S.99 Z8Z.8: 19 residues within 4Å: Chain D: D.56, R.85, R.86, F.88, S.99, I.100, L.190, L.191, F.193, T.204, F.221, I.281, F.284, A.285, T.289, A.350, R.352, E.354 Ligands: HEM.7 13 PLIP interactions: 13 interactions with chain D Hydrophobic interactions: D:F.88, D:F.88, D:I.100, D:I.100, D:L.190, D:L.191, D:F.193, D:F.221, D:I.281, D:F.284, D:F.284, D:A.350 Hydrogen bonds: D:S.99

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sevrioukova, I.F. et al., Pyridine-Substituted Desoxyritonavir Is a More Potent Inhibitor of Cytochrome P450 3A4 than Ritonavir. J.Med.Chem. (2013)

Release Date

2013-04-24

Peptides

Cytochrome P450 3A4: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

C
A

D
A

Cytochrome P450 3A4

Related Entries With Identical Sequence